DOSE RANGING STUDY OF CI-1004 IN PATIENTS WITH OSTEOARTHRITIS

CI-1004 在骨关节炎患者中的剂量范围研究

• 批准号: 6305622
• 负责人: NANCY L LANE
• 金额: $ 0.06万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-12-01 至 2000-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6305622
• 关键词: antiarthritic agent; arthritis therapy; blood chemistry; clinical research; clinical trials; drug screening /evaluation; human subject; human therapy evaluation; osteoarthritis; urinalysis

Patients with hip or knee osteoarthritis will be seen as outpatients for collection of blood and urine at different time points for a 6-week period. Patients will have the option of to participate in a one year open label study.

髋关节或膝盖骨关节炎的患者将被视为在6周期间不同时间点收集血液和尿液的门诊病人。患者可以选择参加一年的公开标签研究。